Heart repair drug shows promise for diabetic kidney patients
NCT ID NCT07442448
First seen Mar 03, 2026 · Last updated May 12, 2026 · Updated 8 times
Summary
This study tests whether the drug finerenone can reduce scarring and fat buildup in the heart muscle of people with diabetic kidney disease and heart failure. Forty participants will take finerenone daily for six months and undergo heart scans before and after treatment. The goal is to see if the drug can reverse or slow harmful heart changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cathay General Hospital
Taipei, Taiwan
Conditions
Explore the condition pages connected to this study.